Financial Perspectives’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.5K Hold
408
0.01% 417
2026
Q1
$25.6K Hold
408
0.01% 409
2025
Q4
$27.1K Hold
408
0.01% 397
2025
Q3
$27.5K Hold
408
0.01% 395
2025
Q2
$35.6K Hold
408
0.01% 352
2025
Q1
$27.9K Hold
408
0.01% 365
2024
Q4
$31.7K Hold
408
0.01% 350
2024
Q3
$27.4K Hold
408
0.01% 349
2024
Q2
$46.3K Hold
408
0.02% 284
2024
Q1
$56.6K Hold
408
0.02% 270
2023
Q4
$50.6K Hold
408
0.02% 270
2023
Q3
$38.1K Hold
408
0.02% 281
2023
Q2
$52.4K Hold
408
0.02% 256
2023
Q1
$47.4K Hold
408
0.02% 263
2022
Q4
$46.2K Hold
408
0.02% 258
2022
Q3
$32.9K Hold
408
0.02% 282
2022
Q2
$30.4K Hold
408
0.02% 296
2022
Q1
$52.2K Hold
408
0.02% 249
2021
Q4
$54.8K Hold
408
0.03% 233
2021
Q3
$55.8K Hold
408
0.03% 228
2021
Q2
$43.6K Hold
408
0.02% 274
2021
Q1
$36.7K Hold
408
0.02% 280
2020
Q4
$37.7K Buy
+408
New +$36.4K 0.02% 258

Other funds holding DXCM

Financial Perspectives's DXCM Position: Q2 2026 in Review

Financial Perspectives held its DexCom (DXCM) position steady in Q2 2026 at 408 shares worth $27.5K. The position accounts for 0.01% of the portfolio, ranked #417.

Financial Perspectives first reported a position in DXCM in Q4 2020 and has held it in 23 quarters since. The position peaked at $56.6K in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Financial Perspectives held 408 shares of DexCom worth $27.5K as of Q2 2026.
  • Financial Perspectives left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.01% of Financial Perspectives's portfolio in Q2 2026, its #417 holding.
  • Financial Perspectives first reported a position in DexCom in Q4 2020 and has held it in 23 quarters since.
  • Financial Perspectives's DexCom position peaked at $56.6K in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.